Skip to content

Pharmacodynamics of pancuronium during therapeutic hypothermia.

Neuromuscular recovery following 24h of pancuronium infusion during post-resuscitation therapeutic hypothermia– an observational prospective study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23344
Enrollment
10
Registered
2011-10-19
Start date
2011-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac arrest, therapeutic hypothermia, neuromuscular blockade, train-of-four, pancuroniumbromide

Interventions

Pancuroniumbromide infusion during 24 hours.

Sponsors

Maastricht University Medical Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient criteria: 1. Age > 18 years. Cooling criteria: 1. Witnessed cardiac arrest; 2. Initial cardiac rhythm being VF/VT; 3. Delay from arrest till start CPR >5min, <15min; 4. Time from arrest till return of spontaneous circulation (ROSC) <60min; 5. Start cooling within 6 hours after ROSC.

Exclusion criteria

Exclusion criteria: Exclusion from cooling (MUMC based): 1. Cardiac shock >30min after ROSC; 2. Coma before cardiac arrest; 3. Other cause of coma (CVA, trauma, intoxication); 4. Hypothermia on arrival at emergency department (15min after ROSC; 8. Terminal disease state; 9. Pre-existing coagulation disorders (trombolysis is no contra-indication); 10. Persistent ventricular arrhythmias. Exclusion because of study criteria: 1. Age < 18 years; 2. Contraindications for use of pancuronium; 3. No option for neuromuscular monitoring on at least one hand; 4. Use of confounding medication (anticonvulsants, steroid therapy, verapamil or aminoglycosides); 5. Renal failure; 6. Liver failure; 7. Neuromuscular diseases; 8. Use of other neuromuscular relaxants than pancuronium.

Design outcomes

Primary

MeasureTime frame
Median during untill TOF ratio 0.9 after 24 hours of pancuroniumbromide infusion.

Contacts

Public ContactL.P.W. Mommers

Maastricht University Medical Centre P. Debyelaan 25

l.mommers@mumc.nl+31 (0)43 3876385

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)